GL1X · GenesisL1 explorer

Research workbench

Structural Insights into the Design of Nonpeptidic Isothiazolidi - Containing Inhibitors of Protein Tyrosine Phosphatase 1B

Analyse Structural Insights into the Design of Nonpeptidic Isothiazolidi - Containing… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2CNH
Type
protein
Length
296 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.8
Source
HOMO SAPIENS
Molecule
Tyrosine-protein phosphatase non-receptor type 1
EC
3.1.3.48
UniProt
P18031
Ligands
IZB, CA
Pockets
1 · best druggability 0.40

Structure

x-ray diffraction · resolution 1.8 · 1 distinct chain · 36% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48)protein29636% helix, 20% strandP18031

Ligands and binding sites

  • IZB · N-[(1S)-1-(1H-benzimidazol-2-yl)-2-{4-[(5S)-1,1-dioxido-3-oxoisothiazolidin-5-yl]phenyl}ethyl]-4-methyl-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.400.8017empty

Compared structures

  • 2CNH · Structural insights into the design of nonpeptidic isothiazolidinone- containing… · the same entry in another collection · chain A against A, TM-score 1.00
  • P18031 · AlphaFold monomer V2.0 prediction for tyrosine-protein phosphatase non-receptor type 1… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.